DNA Microarray Market Report 2026

DNA Microarray Market Overview

• DNA Microarray market size has reached to $3.78 billion in 2025 • Expected to grow to $6.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Personalized Medicine Drives DNA Microarray Market Growth • Market Trend: Advancement In DNA Microarray Technology With Two-Day Turnaround • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under DNA Microarray Market?

A deoxyribonucleic acid (DNA) microarray is a powerful tool used in molecular biology to simultaneously measure the expression levels of thousands of genes. It consists of tiny spots, or probes, containing known DNA sequences immobilized on a solid surface. When a sample containing fluorescently labeled DNA is applied to the microarray, the degree of fluorescence at each spot indicates the expression level of the corresponding gene, allowing researchers to study gene expression patterns and identify biomarkers associated with various diseases or experimental conditions. The main types of DNA microarrays are complementary DNA microarrays, oligonucleotide DNA microarrays, and others. Complementary DNA is a powerful research tool used to analyze gene expression levels across a large number of genes simultaneously. These have found applications in gene expression analysis, genotyping, and others and are used by several end-users, mainly pharmaceutical and biotechnology companies, diagnostic centers, hospitals and clinics, academic and research institutes, and others.

What Is The DNA Microarray Market Growth Forecast?

The dna microarray market size is expected to see rapid growth in the next few years. It will grow to $6.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to precision medicine research, integration with ai analytics, translational genomics growth, drug target identification, personalized healthcare research. Major trends in the forecast period include growing use of gene expression profiling, expansion of microarray applications in research, increased adoption in biomarker discovery, integration with advanced data analysis tools, demand for high-throughput genomic screening.

What Is The Driver Of The DNA Microarray Market?

The rapid adoption of personalized medicine is expected to propel the growth of the DNA microarray market going forward. Personalized medicine refers to the tailoring of medical treatment to the individual characteristics of each patient, including genetic, environmental and lifestyle factors. Its adoption is increasing because advances in ‘omics’ technologies, data-integration capabilities and growing awareness among healthcare professionals and patients are making patient-specific therapies more viable and accessible. The DNA microarray market supports this trend by enabling gene expression profiling and genomic analysis that form the foundation for individualised treatment plans and precision diagnostics. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organisation, the U.S. Food and Drug Administration (FDA) approved 16 novel personalized therapies for rare diseases in 2023, compared to 6 in 2022, signalling accelerated uptake of precision medicine approaches. Therefore, the rapid adoption of personalized medicine is driving the growth of the DNA microarray industry.

Key Players In The Global DNA Microarray Market

Major companies operating in the dna microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

Global DNA Microarray Market Trends and Insights

Major companies operating in the DNA microarray market are focusing on developing advanced technologies such as rapid-turnaround microarray platforms to improve workflow efficiency, accelerate data delivery, and strengthen competitiveness. A rapid-turnaround microarray platform refers to a high-resolution genomic analysis system designed to generate comprehensive results within a shortened timeframe such as two days supporting faster research progress and more timely clinical decision-making. For instance, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced the Applied Biosystems CytoScan HD Accel array, a chromosomal microarray offering a leading two-day turnaround time and enhanced whole-genome coverage in more than 5,000 key genomic regions, enabling cytogenetic laboratories to achieve higher productivity, improved efficiency, and more actionable insights for prenatal, postnatal, and oncology research.

What Are Latest Mergers And Acquisitions In The DNA Microarray Market?

In May 2023, Thermo Fisher Scientific, a US-based scientific services company, partnered with Qatar Genome Program (QGP) for an undisclosed amount. Through this partnership, Thermo Fisher aims to advance precision medicine efforts for Arab populations by co-developing a custom Axiom genotyping array that leverages whole-genome sequencing data from 19 Arab countries. Qatar Genome Program (QGP) is a Qatar-based national population-level research initiative focused on building genomic datasets to support precision health programs.

What Defines the DNA Microarray Market?

The DNA microarray market consists of sales of DNA microarray chips, microarray scanners, and microarray printers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the DNA Microarray Market Report 2026?

The dna microarray market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dna microarray industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.